Request a Free Sample to learn more about this report
AIRWAY STENT/LUNG STENT MARKET REPORT OVERVIEW
The Airway Stent/Lung Stent Market Size is Projected to be worth US$ 89.59 Million in 2023. The Market is likely to Surpass US$ 188.27 Million by 2032 at a CAGR of 7.71% During the Forecast period [2024-2032].
Airway stent or lung stent are the hollow tube-like structures which are designed purposely to remove airway obstruction and maintain airway patency. These are designed in such a way to manage complex air conditions such as air flow. The main aim of lung or airway stents are to keep the airways clear and free of obstructions to reduce respiratory issues, helpful in a various respiratory illness, such as tumors, tracheobronchial strictures, and stenosis brought on by inflammation or external pressures, are treated with airway stents. As the incidence of respiratory is in prevalence, so the Patients with lung cancer, various respiratory disorders, including chronic obstructive pulmonary disease are also treated with these airway or lung stents. They offer sufficient patency for a maximum of one year and are simple to install. Tissue expansion through the mesh, however, may result in issues. Medical-grade silicone is used to make silicone stents, which are less likely to encourage tissue growth. But because of their physical characteristics, they are a little more difficult to locate precisely.
The factors prevailing the market growth are robust healthcare infrastructure and adoption of cutting-edge technology to treat various respiratory illness. The region which will dominate the sector due to advanced innovation is the North America. Another trend augmenting market growth is the usage of hybrid stents to clear airway passage or other obstruction. One of the key factors anticipated to accelerate the growth and demand for lung stents and airway stents is the rise in the prevalence of respiratory illnesses and lung cancer. Furthermore, the increased use of therapeutic treatments including chemotherapies, bronchoscopies, and endoscopic therapy as a result of the high prevalence of lung cancer and the aging population is anticipated to fuel the expansion of the global market during projection period. The consumers are more inclined towards minimally invasive procedures augmenting market growth and the healthcare sector is rapidly expanding is anticipated to contribute to the market's expansion. In addition, rising rates of COPD and post-tuberculosis stenosis, as well as substantial funding from both public and private sources for the creation of non-vascular stents, are among the key elements anticipated to drive the market for lung and airway stents.
COVID-19 Impact: Sharp Decline In Demand Due To Lockdown Restrictions
The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.
In the harsh time of covid pandemic, almost everyone chooses home-made kadha, which was an ayurvedic preparation, and acted as life savior for many of us. During the Covid pandemic, when the entire world as suffering from the ill effects of virus, the allopathic medications was not enough to everyone due to restricted outings, the medications was a life jacket for many of us. Numerous business groups have been significantly impacted by the way COVID-19 pandemic, including the Airway Stent/Lung Stent Marketplace. Due to the pandemic effects on traditional training programs and education techniques, online learning and training platforms the trademark ranges, gaining more attention among consumers. Many organizations have shut down their ongoing projects due to hindered production unit and supply chain. This program has become vital for medical and anatomical students who want to continue their education and training remotely. The market had rapid development during the pandemic and is expected to continue in the future. These challenges include a considerable demand in the form of time, space and resources, among other things, which can be quite difficult for establishments of education. Accordingly, due to the shift to online platforms that have forced educators to rethink approaches, innovative solutions have been developed to cope with the constraints of traditional anatomy labs while providing fully-fledged learning environments for the students. The market for airway stent/lung stent was also affected. The COVID-19 pandemic did have an impact on the airway stent/lung stent production process, but because people were more cautious about their health today, the government established restrictions that were advantageous to the ayurvedic industry. Airway stent/lung stent helped the world combat COVID-19 during the pandemic when all allopathic medications failed.
LATEST TRENDS
"Acceptance Of Hybrid Stents Leads To Market Expansion"
The market for lung stents has significant room to develop thanks to the usage of hybrid stents. The advantages of both types of stents are provided by hybrid stents, which combine metal and polymer components. They avoid the long-term problems linked to permanent metal implants inside the body while providing the structural stability and accuracy of metal stent insertion. The polymer component is made to be more biodegradable and to improve sealing properties. Compared to conventional metal stents, this can assist lower issues like migration or granuloma formation over time. Hybrid stents are now a feasible option for a greater variety of lung disorders because to recent advancements. Thin, flexible designs that can better navigate intricate airway anatomy are now possible because to new fabrication techniques. Additionally, certain hybrid stents have the ability to elute drugs and modify their surfaces for targeted therapy. As a result, its usage in treating benign reasons other than malignant airway blockages is growing.
Request a Free Sample to learn more about this report
AIRWAY STENT/LUNG STENT MARKET SEGMENTATION
By Type
Based on type the global market can be categorized into Tracheal Stents, Laryngeal Stents.
- Tracheal Stents: This segment include tracheal stents which are hollow tube-like structure of various shapes and sizes and can be absorbable or non-absorbable. There main purpose is to remove airway obstruction and maintain airway patency.
- Laryngeal Stents: This segment includes laryngeal stents which are designed in such a way to manage complex air conditions such as air flow. The major goals are to keep the airways open and free of obstructions.
By Application
Based on application the global market can be categorized into Hospitals, Ambulatory Surgery Centres.
- Hospitals: This segment includes the advantage of airway stent/lung stent in medical industry for hospitals. Hospitals utilize such hollow tube-like structure to remove airway passage obstruction in the respiratory illness.
- Ambulatory Surgery Centres: This segment includes ambulatory surgery centres are the establishments where treatment carried out without hospital admission. At Ambulatory surgery centres, services are more affordable services in a less stressful and comfortable manner than many hospitals can.
DRIVING FACTORS
"Growing Interest In Less Invasive Methods Will Boost The Market Growth"
One of the major trends fostering Airway Stent/Lung Stent Market growth is growing interest in less invasive methods across the globe. The need for less intrusive procedures is largely to blame for the lung stent market's rapid expansion. Requirement of less invasive procedures is more fascinating for consumers to get their respiratory issues treated will lead to market expansion. Because minimally invasive techniques have so many advantages over open surgery, their use has become more common in numerous medical fields in recent years. Following minimally invasive procedures, patients have less pain, fewer complications, a lower risk of infection, a shorter hospital stay, and a quicker pace of recovery. Many healthcare industries are adopting various innovative ideas to treat respiratory illness which is gaining manufacturers attraction to enhance the productivity. Many lung illnesses can be addressed with minimally invasive thoracoscopy or bronchoscopy lung stenting procedures. This has led to a rise in the use of lung stents, which are used to preserve or widen the airways by inserting them into minor incision sites or naturally occurring holes. For example, lung stents are often used to treat central airway obstructions caused by lung cancer, COPD, or tumors. They assist people in breathing better and regaining airflow. Lung stents are now considered the standard of care for treating a variety of lung disorders including airway blockages due to their non-invasive nature and positive results.
"Growing Need For Hybrid And Silicone Stents Will Expand The Market Growth"
Another factor propelling market growth is the growing requirement of hybrid and silicone stents across the globe. The market for lung stents is being significantly impacted by the growing demand for silicone and hybrid stents. Because of their many therapeutic advantages over conventional metal stent designs, these newer generation stents are gradually taking the lead in lung stent treatments. Because silicone and hybrid stents are made of a more flexible material than metal, they have better biocompatibility and a lower chance of stent fractures. This enables individuals to adjust to their natural body motions and the dynamic lung environment more effectively. These stents' increased compliance leads to better air leak site sealing and increased efficacy in preserving bronchial patency over extended periods of time. Because of their softer texture, they also result in less damage to the lung tissue during the insertion and retrieval processes.
RESTRAINING FACTORS
"Hazard Of Stent Migration Or Blockage Potentially Impede Market Growth"
One of the main obstacles impeding the lung stent market's growth is the possibility of stent migration or occlusion. Stent migration is the unintended migration of the stent from its original location in the lungs, whereas obstruction is the stent's gradual blockage of the airways. Patients may experience serious health effects from either of these events. To maintain airways, open in diseases like lung cancer, lung stents are either inserted through open chest surgery or minimally invasive techniques like bronchoscopy. On the other hand, the lungs are dynamic organs that continuously contract and expand while you breathe. Compared to other sections of the body, lung stents are therefore more likely to eventually migrate from their original location. Other airways may become blocked by migration, among other issues. In a similar vein, lung tissue keeps growing around the stent, obstructing air flow. This leads to problems with blockage. However, the market for lung stents and airway stents is expected to grow less due to the easy access to alternative treatments and the decline in tobacco smoking prevalence. On the other hand, the market may grow less due to stent-related complications and a shortage of medical professionals to perform the procedure.
Request a Free Sample to learn more about this report
AIRWAY STENT/LUNG STENT MARKET REGIONAL INSIGHTS
The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.
"North America Dominating the Market due to Presence of a Large Consumer Base"
Countries like US and Canada are easily accessible, it is anticipated that North America will lead the largest revenue of Airway Stent/Lung Stent Market share during projection period. The region is witnessing remarkable growth opportunities due to increase in hospitalizations for respiratory conditions creating a dominance in the sector. For example, the most recent figures show that one in seven Americans who are middle-aged or older have lung issues. The industries and manufacturers are putting their emphasis on offering efficient treatment alternatives which will impact the development of the regional industry. In the region, the rising prevalence of respiratory conditions including lung cancer and chronic obstructive pulmonary disease is one of the major propelling reasons for market extension. Lung cancer is the primary cause of cancer-related fatalities in the United States for both men and women, according to the American Lung Association. The region's high rate of respiratory conditions has raised demand for airway stents, propelling the market's expansion. North America is anticipated to have well-established healthcare infrastructure and availability of cutting-edge medical technologies which is fueling market growth on a large scale. The latest medical technology is available in many of the region's hospitals and healthcare institutions, allowing for the use of airway stents in the diagnosis and treatment of respiratory problems. Innovation and technology adoption strengthen the region and create its overall market dominance. Alongside other regions, North America plays a core role in the ongoing growth of the market however, the region’s superior academic and healthcare environment solidifies its role as a major hub for the deployment and utilization of airway stent/lung stent for medical education, research and clinical practice. The market for pulmonary stents has also expanded as a result of the high healthcare costs in the area. In contrast, North America is anticipated to increase at the fastest rate over the course of the projection period due to the rising prevalence of heart disease and asthma brought on by the expansion of the pharmaceutical sector. Because of this, North America is distinguished as a major player in the worldwide electronic drug delivery systems market, setting the bar for effectiveness, cutting edge technology, and environmental responsibility.
KEY INDUSTRY PLAYERS
"Key Industry Players Shaping the Market through Innovation and Market Expansion"
The Airway Stent/Lung Stent Market is significantly influenced by key industry players that play a pivotal role in driving market dynamics and shaping consumer preferences. These key players possess extensive retail networks and online platforms, providing consumers with easy access to a wide variety of options. These principal implementers are engaging themselves to create cutting-edge software packages that offer students of medicine a more realistic and fun-filled learning atmosphere. Through their efforts to innovate, they are aimed at the fast-growing market for medical equipment which utilizes the technology to improve the effectiveness of teaching as well as learning processes in educational institutions. Their strong global presence and brand recognition have contributed to increased consumer trust and loyalty, driving product adoption. These industrial titans also consistently fund R&D, bringing cutting-edge designs, materials, and clever features to meet the changing demands and tastes of consumers. These big businesses' combined efforts have a big impact on the market's future direction and level of competition.
LIST OF MARKET PLAYERS PROFILED
- Micro-Tech (Nanjing) (China)
- Boston Scientific (U.S.)
- Novatech Sa (France)
- Endo-Flex (Germany)
- Taewoong Medical (South Korea)
- Teleflex (U.S.)
- Hood Laboratories (U.S.)
- Cook Group (U.S.)
- Fuji Systems (India)
- Merit Medical Systems (U.S.)
- Efer Endoscopy (France)
INDUSTRIAL DEVELOPMENT
August 2023: Theken Companies, a family of American manufacturers of medical implants, purchased VisionAir Solutions, a Cleveland Clinic spinout company with a focus on technology. With its cutting-edge technology, VisionAir produces anatomically-specific 3D-printed airway stents for each patient.
REPORT COVERAGE
The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.
The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 89.59 Million in 2023 |
Market Size Value By |
US$ 188.27 Million by 2032 |
Growth Rate |
CAGR of 7.71% from 2023 to 2032 |
Forecast Period |
2032 |
Base Year |
2023 |
Historical Data Available |
2019-2022 |
Regional Scope |
Global |
Segments Covered |
Type and Application |
-
What value is the airway stent/lung stent market expected to touch by 2032?
The global airway stent/lung stent market is expected to reach USD 188.27 million by 2032.
-
What CAGR is the airway stent/lung stent market expected to exhibit by 2032?
The airway stent/lung stent market is expected to exhibit a CAGR of 7.71% by 2032.
-
Which are the driving factors of the airway stent/lung stent market?
Growing interest in less invasive methods and growing need for hybrid and silicone stents are some of the driving factors of the market.
-
What are the key airway stent/lung stent market segments?
The key market segmentation that you should be aware of, which include, Based on type the airway stent/lung stent market is classified as Tracheal Stents, Laryngeal Stents. Based on application the airway stent/lung stent market is classified as Hospitals, Ambulatory Surgery Centres.